Literature DB >> 10037258

Insulin and TSH promote growth in size of PC Cl3 rat thyroid cells, possibly via a pathway different from DNA synthesis: comparison with FRTL-5 cells.

T Kimura1, J E Dumont, A Fusco, J Golstein.   

Abstract

In the rat thyroid cell lines PC Cl3, FRTL- 5 and WRT, proliferation is mainly regulated by insulin or IGF, and TSH. However, the mechanism regulating cell mass doubling prior to division is still unknown. Our laboratory has shown that in dog thyroid cells insulin promotes growth in size while TSH in the presence of insulin triggers DNA replication. In the absence of insulin, TSH has no effect on cell growth. In this report we investigated insulin action on both cell mass and DNA synthesis and its modulation by TSH and insulin in PC Cl3 and FRTL-5 cells. In PC Cl3 cells, insulin activated not only DNA synthesis but also protein synthesis and accumulation. Although TSH potentiated the stimulation of DNA synthesis induced by insulin, enhancement of protein synthesis by both agents was additive. All TSH effects were reproduced by forskolin. Similar effects were also obtained in FRTL-5 cells. This suggests that insulin and TSH, via cAMP, modulate both growth in size and DNA replication in these cell lines. Lovastatin, which blocks 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreased the induction of DNA synthesis, but not of protein synthesis induced by insulin or TSH in PC Cl3 cells. In FRTL-5 cells, lovastatin reduced protein and DNA synthesis stimulated by insulin but not TSH-induced protein synthesis. Taking these data together, we propose that insulin and/or TSH both modulate cell mass doubling and DNA synthesis in these cell lines, presumably via different pathways, and that there are at least two pathways which regulate growth in size in FRTL-5 thyroid cells: one triggered by insulin, which is lovastatin sensitive, and the other activated by TSH, which is not sensitive to lovastatin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037258     DOI: 10.1530/eje.0.1400094

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4.

Authors:  Sara Blancquaert; Lifu Wang; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Thurl E Harris; Pierre P Roger
Journal:  Mol Endocrinol       Date:  2010-05-19

2.  Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland.

Authors:  M P Postiglione; R Parlato; A Rodriguez-Mallon; A Rosica; P Mithbaokar; M Maresca; R C Marians; T F Davies; M S Zannini; M De Felice; R Di Lauro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

3.  Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece.

Authors:  Elias Sozopoulos; Helen Litsiou; Gerassimos Voutsinas; Nikolaos Mitsiades; Nikolaos Anagnostakis; Thomais Tseva; Efstratios Patsouris; Sofia Tseleni-Balafouta
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

4.  Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.

Authors:  Yevgeniya S Kushchayeva; Sergiy V Kushchayev; Megan Startzell; Elaine Cochran; Sungyoung Auh; Yuhai Dai; Marissa Lightbourne; Monica Skarulis; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

5.  On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entry requires activated and phosphorylated Rap1b.

Authors:  Fernando Ribeiro-Neto; Julie Urbani; Nicolas Lemee; Liguang Lou; Daniel L Altschuler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

6.  Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.

Authors:  Maria Letizia Motti; Daniela Califano; Giancarlo Troncone; Carmela De Marco; Ilenia Migliaccio; Emiliano Palmieri; Luciano Pezzullo; Lucio Palombini; Alfredo Fusco; Giuseppe Viglietto
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter.

Authors:  Yasemin Aydoğan; Mustafa Altay; Oktay Ünsal; Veysel Kaplanoğlu; Yavuz Çağır; Canan Yıldız; Esin Beyan; Selma Uysal Ramadan
Journal:  Endocrine       Date:  2018-08-06       Impact factor: 3.633

8.  The role of insulin-like growth factor 1 in the development of benign and malignant thyroid nodules.

Authors:  Engin Baştürk; Metin Kement; Dilek Yavuzer; Selahattin Vural; Cem Gezen; Hülya Ilıksu Gözü; Ayşe Karadayı; Mustafa Oncel
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

9.  Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.

Authors:  V Vasko; M Saji; E Hardy; M Kruhlak; A Larin; V Savchenko; M Miyakawa; O Isozaki; H Murakami; T Tsushima; K D Burman; C De Micco; M D Ringel
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

10.  The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.

Authors:  M Mandal; S Kim; M N Younes; S A Jasser; A K El-Naggar; G B Mills; J N Myers
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.